Author
Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals.
Sun Pharmaceutical Industries Ltd will shut down some of its manufacturing plants in India as well as overseas as the company will continue trimming its large manufacturing base as part of cost optimisation
Read More-470.jpg)
Until recently, doctors had to double up as administrators at hospitals. Now, with some colleges training managers specifically for the healthcare industry, the doctors can go back to doing what they do best
Read More
The acquisition will help Essel unlock synergies such as enhanced cross selling opportunity in the German markets, sourcing flexibility and better capacity utilization at all of its Europe plants
Read More
Tata steel posted a loss of Rs 2,833 crore during the quarter ended June 30, 2016 mainly on account of the loss from discontinued operations of Rs 3,296 crores recognised with divestment of its long product unit in the UK, which was completed during the quarter
Read More
Nissan India's Chennai plant has exported more than 620,000 cars since the operations began at this facility in 2010
Read More
With India’s regulatory mechanism as weak as it is, the latest government advisory could end up being the pass to small-time players to push their subpar products into government hospitals under a competitive price tag
Read More
The Future Group plans 4,000 physical stores by 2021, demonstrating its determination to broaden its horizon. Meanwhile, Kishore Biyani is looking at more online acquisitions too
Read More
Load factor reached a record high and is reflected in the total passengers carried, says AirAsia’s Group Chief Executive Officer Tony Fernandes
Read More
US Patent and Trade Mark Office’s decision to reject the patent claims of Teva Pharmaceutical Industries on its 40-milligram dosage of multiple sclerosis drug Copaxone is undoubtedly a booster dose for the generic drug industry and the Indian drug makers in particular
Read More
The pharma major has been moulting since 2012, but will the recent management rejig jolt the transformation?
Read More
